Healthcare provider profile · identity verified

Nicky Edwards, APN

Nurse Practitioner · HOHENWALD, TN · NPI 1336531698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	288	86
Lisinopril	Lisinopril	274	82
Levothyroxine Sodium	Levothyroxine Sodium	266	74
Amlodipine Besylate	Amlodipine Besylate	211	63
Rosuvastatin Calcium	Rosuvastatin Calcium	196	73
Pantoprazole Sodium	Pantoprazole Sodium	179	55
Losartan Potassium	Losartan Potassium	154	48
Metformin Hcl	Metformin Hcl	153	51
Gabapentin	Gabapentin	147	30
Potassium Chloride	Potassium Chloride	134	36
Albuterol Sulfate Hfa	Albuterol Sulfate	131	44
Metoprolol Tartrate	Metoprolol Tartrate	126	39
Omeprazole	Omeprazole	118	32
Ozempic	Semaglutide	118	23
Methylprednisolone	Methylprednisolone	116	98
Furosemide	Furosemide	110	38
Trazodone Hcl	Trazodone Hcl	103	26
Alendronate Sodium	Alendronate Sodium	102	30
Duloxetine Hcl	Duloxetine Hcl	95	24
Montelukast Sodium	Montelukast Sodium	87	31
Tizanidine Hcl	Tizanidine Hcl	86	41
Citalopram Hbr	Citalopram Hydrobromide	85	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	80	64
Fluoxetine Hcl	Fluoxetine Hcl	79	22
Alprazolam	Alprazolam	75	14
Metoprolol Succinate	Metoprolol Succinate	73	22
Meloxicam	Meloxicam	68	24
Escitalopram Oxalate	Escitalopram Oxalate	66	28
Tamsulosin Hcl	Tamsulosin Hcl	66	23
Hydrochlorothiazide	Hydrochlorothiazide	64	20
Glipizide	Glipizide	58	20
Fluconazole	Fluconazole	57	31
Lovastatin	Lovastatin	56	14
Ondansetron Hcl	Ondansetron Hcl	53	32
Pravastatin Sodium	Pravastatin Sodium	53	16
Sertraline Hcl	Sertraline Hcl	53	13
Clopidogrel	Clopidogrel Bisulfate	51	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	13
Mirtazapine	Mirtazapine	48	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	47	44
Ropinirole Hcl	Ropinirole Hcl	46	suppressed
Glipizide Er	Glipizide	45	13
Jardiance	Empagliflozin	45	15
Breo Ellipta	Fluticasone/Vilanterol	44	suppressed
Carvedilol	Carvedilol	40	11
Fluticasone Propionate	Fluticasone Propionate	40	22
Spironolactone	Spironolactone	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	12
Meclizine Hcl	Meclizine Hcl	34	15
Nystatin	Nystatin	34	22
Eliquis	Apixaban	32	13
Lansoprazole	Lansoprazole	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	30	suppressed
Chlorthalidone	Chlorthalidone	30	11
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Allopurinol	Allopurinol	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	27
Sucralfate	Sucralfate	28	suppressed
Famotidine	Famotidine	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Torsemide	Torsemide	27	suppressed
Cephalexin	Cephalexin	26	24
Ezetimibe	Ezetimibe	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Promethazine Hcl	Promethazine Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Atenolol	Atenolol	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Azithromycin	Azithromycin	20	20
Bupropion Xl	Bupropion Hcl	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Clonazepam	Clonazepam	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Simvastatin	Simvastatin	19	suppressed
Clindamycin Hcl	Clindamycin Hcl	18	16
Gemfibrozil	Gemfibrozil	18	suppressed
Prasugrel Hcl	Prasugrel Hcl	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Amoxicillin	Amoxicillin	17	17
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Prednisone	Prednisone	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Baclofen	Baclofen	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Linzess	Linaclotide	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Dupixent Pen	Dupilumab	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Cosentyx Sensoready Pen	Secukinumab	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	12
Synthroid	Levothyroxine Sodium	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Glimepiride	Glimepiride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error